NDC 59282-108 - Encore Activator
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59282-108
- Package NDCs from labels
- 59282-108-17, 59282-108-21
- Manufacturer
- ABS Global Inc.
- Effective date
- 2021-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Encore Activator - ABS Global Inc. | ABS Global Inc. | 2021-10-28 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59282-108-17 | Encore Activator | 56780 mL in 1 DRUM | SOLUTION | 56780 | 4 | |
| 59282-108-21 | Encore Activator | 208200 mL in 1 DRUM | SOLUTION | 208200 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CHLOROUS ACID | ACTIVE INGREDIENT | 7JRT833T5M | ENCORE ACTIVATOR (CHLORUS ACID) SOLUTION [ABS GLOBAL INC.] | 1 | |
| CHLOROUS ACID | ACTIVE MOIETY | 7JRT833T5M | ENCORE ACTIVATOR (CHLORUS ACID) SOLUTION [ABS GLOBAL INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ENCORE ACTIVATOR (CHLORUS ACID) SOLUTION [ABS GLOBAL INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.